Medicon Hellas S.A. (ATH:MEDIC)

Market Cap	9.19M
Revenue (ttm)	17.99M
Net Income (ttm)	820.81K
Shares Out	4.42M
EPS (ttm)	0.19
PE Ratio	10.92
Forward PE	n/a
Dividend	0.06 (2.88%)
Ex-Dividend Date	Jul 15, 2024

Volume	30
Average Volume	2,484
Open	2.080
Previous Close	2.040
Day's Range	2.080 - 2.080
52-Week Range	1.940 - 3.050
Beta	0.52
RSI	46.93
Earnings Date	Apr 29, 2025

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer system for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calib...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1988
• Employees: 174
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: MEDIC

Financial Performance

In 2023, Medicon Hellas's revenue was 18.72 million, a decrease of -9.89% compared to the previous year's 20.77 million. Earnings were 1.32 million, a decrease of -47.83%.